Janine T Hidding1, Peter B Viehoff2, Carien H G Beurskens3, Hanneke W M van Laarhoven4, Maria W G Nijhuis-van der Sanden5, Philip J van der Wees6. 1. J.T. Hidding, PT, MSc, Department of Orthopedics, Section of Physical Therapy, Radboud University Medical Center, Geert Groteplein Noord 21, Nijmegen 6525 EZ, the Netherlands, and Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Nijmegen, the Netherlands. Janine.Hidding@radboudumc.nl. 2. P.B. Viehoff, PT, PhD, Department of Dermatology, Erasmus Medical Centre, Rotterdam, the Netherlands, and Centre for Physical and Manual Therapy 't Gilde, Gorinchem, the Netherlands. 3. C.H.G. Beurskens, PT, PhD, Department of Orthopedics, Section of Physical Therapy, Radboud University Medical Center. 4. H.W.M. van Laarhoven, MD, PhD, Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. 5. M.W.G. Nijhuis-van der Sanden, PT, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare). 6. P.J. van der Wees, PT, PhD, Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare).
Abstract
BACKGROUND: Lymphedema is a common complication of cancer treatment, resulting in swelling and subjective symptoms. Reliable and valid measurement of this side effect of medical treatment is important. PURPOSE: The purpose of this study was to provide best evidence regarding which measurement instruments are most appropriate in measuring lymphedema in its different stages. DATA SOURCES: The PubMed and Web of Science databases were used, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. STUDY SELECTION: Clinical studies on measurement instruments assessing lymphedema were reviewed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) scoring instrument for quality assessment. DATA EXTRACTION: Data on reliability, concurrent validity, convergent validity, sensitivity, specificity, applicability, and costs were extracted. DATA SYNTHESIS: Pooled data showed good intrarater intraclass correlation coefficients (ICCs) (.89) for bioimpedance spectroscopy (BIS) in the lower extremities and high intrarater and interrater ICCs for water volumetry, tape measurement, and perometry (.98-.99) in the upper extremities. In the upper extremities, the standard error of measurement was 3.6% (σ=0.7%) for water volumetry, 5.6% (σ=2.1%) for perometry, and 6.6% (σ=2.6%) for tape measurement. Sensitivity of tape measurement in the upper extremities, using different cutoff points, varied from 0.73 to 0.90, and specificity values varied from 0.72 to 0.78. LIMITATIONS: No uniform definition of lymphedema was available, and a gold standard as a reference test was lacking. Items concerning risk of bias were study design, patient selection, description of lymphedema, blinding of test outcomes, and number of included participants. CONCLUSIONS: Measurement instruments with evidence for good reliability and validity were BIS, water volumetry, tape measurement, and perometry, where BIS can detect alterations in extracellular fluid in stage 1 lymphedema and the other measurement instruments can detect alterations in volume starting from stage 2. In research, water volumetry is indicated as a reference test for measuring lymphedema in the upper extremities.
BACKGROUND:Lymphedema is a common complication of cancer treatment, resulting in swelling and subjective symptoms. Reliable and valid measurement of this side effect of medical treatment is important. PURPOSE: The purpose of this study was to provide best evidence regarding which measurement instruments are most appropriate in measuring lymphedema in its different stages. DATA SOURCES: The PubMed and Web of Science databases were used, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. STUDY SELECTION: Clinical studies on measurement instruments assessing lymphedema were reviewed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) scoring instrument for quality assessment. DATA EXTRACTION: Data on reliability, concurrent validity, convergent validity, sensitivity, specificity, applicability, and costs were extracted. DATA SYNTHESIS: Pooled data showed good intrarater intraclass correlation coefficients (ICCs) (.89) for bioimpedance spectroscopy (BIS) in the lower extremities and high intrarater and interrater ICCs for water volumetry, tape measurement, and perometry (.98-.99) in the upper extremities. In the upper extremities, the standard error of measurement was 3.6% (σ=0.7%) for water volumetry, 5.6% (σ=2.1%) for perometry, and 6.6% (σ=2.6%) for tape measurement. Sensitivity of tape measurement in the upper extremities, using different cutoff points, varied from 0.73 to 0.90, and specificity values varied from 0.72 to 0.78. LIMITATIONS: No uniform definition of lymphedema was available, and a gold standard as a reference test was lacking. Items concerning risk of bias were study design, patient selection, description of lymphedema, blinding of test outcomes, and number of included participants. CONCLUSIONS: Measurement instruments with evidence for good reliability and validity were BIS, water volumetry, tape measurement, and perometry, where BIS can detect alterations in extracellular fluid in stage 1 lymphedema and the other measurement instruments can detect alterations in volume starting from stage 2. In research, water volumetry is indicated as a reference test for measuring lymphedema in the upper extremities.
Authors: Brian J Loyd; Scott Stackhouse; Michael Dayton; Craig Hogan; Michael Bade; Jennifer Stevens-Lapsley Journal: Knee Date: 2019-02-14 Impact factor: 2.199
Authors: David Latz; Lisa Oezel; Roman Taday; Sebastian Viktor Gehrmann; Joachim Windolf; Erik Schiffner Journal: PLoS One Date: 2022-06-23 Impact factor: 3.752
Authors: Bryan Spinelli; Michael J Kallan; Xiaochen Zhang; Andrea Cheville; Andrea Troxel; Joy Cohn; Lorraine Dean; Kathleen Sturgeon; Margaret Evangelista; Zi Zhang; David Ebaugh; Kathryn H Schmitz Journal: Arch Phys Med Rehabil Date: 2018-10-04 Impact factor: 3.966
Authors: Larissa Nekhlyudov; Grace B Campbell; Kathryn H Schmitz; Gabriel A Brooks; Anita J Kumar; Patricia A Ganz; Diane Von Ah Journal: Cancer Date: 2021-09-16 Impact factor: 6.921
Authors: Cheryl L Brunelle; Sacha A Roberts; Nora K Horick; Tessa C Gillespie; Jamie M Jacobs; Kayla M Daniell; George E Naoum; Alphonse G Taghian Journal: Phys Ther Date: 2020-12-07
Authors: Sacha A Roberts; Tessa C Gillespie; Amy M Shui; Cheryl L Brunelle; Kayla M Daniell; Joseph J Locascio; George E Naoum; Alphonse G Taghian Journal: Cancer Date: 2021-07-27 Impact factor: 6.860
Authors: Nur Amalina Che Bakri; Richard M Kwasnicki; Kieran Dhillon; Naairah Khan; Omar Ghandour; Alexander Cairns; Ara Darzi; Daniel R Leff Journal: Ann Surg Oncol Date: 2021-07-26 Impact factor: 5.344